1. bookVolume 49 (2022): Edizione 3 (October 2022)
Dettagli della rivista
Prima pubblicazione
05 Nov 2014
Frequenza di pubblicazione
4 volte all'anno
Accesso libero

Probiotic Use in Preterm Neonates: A Review and Bibliometric Analysis

Pubblicato online: 26 Oct 2022
Volume & Edizione: Volume 49 (2022) - Edizione 3 (October 2022)
Pagine: 58 - 67
Ricevuto: 01 Jul 2022
Accettato: 16 Sep 2022
Dettagli della rivista
Prima pubblicazione
05 Nov 2014
Frequenza di pubblicazione
4 volte all'anno

1. Larroque B, Bréart G, Kaminski M, et al. Survival of very preterm infants: Epipage, a population based cohort study. Arch Dis Child – Fetal Neonatal Ed. 2004;89(2):F139–44.10.1136/adc.2002.020396175602214977898 Search in Google Scholar

2. Berrington JE, Hearn RI, Bythell M et al. Deaths in Preterm Infants: Changing Pathology Over 2 Decades. J Pediatr. 2012;160(1):49-53.e1.10.1016/j.jpeds.2011.06.04621868028 Search in Google Scholar

3. Alsaied A, Islam N, Thalib L. Global incidence of Necrotizing Enterocolitis: a systematic review and Meta-analysis. BMC Pediatr. 2020;20(1):344.10.1186/s12887-020-02231-5735900632660457 Search in Google Scholar

4. Embleton ND, Skeath T. Probiotics for preterm infants on the NICU. Paediatr Child Health. 2014;24(1):38-40.10.1016/j.paed.2013.07.003 Search in Google Scholar

5. Guner YS, Friedlich P, Wee CP et al. State-Based Analysis of Necrotizing Enterocolitis Outcomes1. J Surg Res. 2009;157(1):21-9.10.1016/j.jss.2008.11.00819615694 Search in Google Scholar

6. Ma B, McComb E, Gajer P, et al. Microbial Biomarkers of Intestinal Barrier Maturation in Preterm Infants. Front Microbiol. 2018;9:2755. doi: 10.3389/fmicb.2018.02755.624663630487786 Apri DOISearch in Google Scholar

7. Battersby C, Santhalingam T, Costeloe K, Modi N. Incidence of neonatal necrotising enterocolitis in high-income countries: a systematic review. Arch Dis Child – Fetal Neonatal Ed. 2018;103(2):F182-9.10.1136/archdischild-2017-31388029317459 Search in Google Scholar

8. Overman RE, Criss CN, Gadepalli SK. Necrotizing enterocolitis in term neonates: A different disease process? J Pediatr Surg. 2019;54(6):1143-6.10.1016/j.jpedsurg.2019.02.04630871720 Search in Google Scholar

9. Cuna A, George L, Sampath V. Genetic predisposition to necrotizing enterocolitis in premature infants: Current knowledge, challenges, and future directions. Semin Fetal Neonatal Med. 2018;23(6):387-93.10.1016/j.siny.2018.08.006662670630292709 Search in Google Scholar

10. Bergmann KR, Liu SXL, Tian R, et al. Bifi dobacteria Stabilize Claudins at Tight Junctions and Prevent Intestinal Barrier Dysfunction in Mouse Necrotizing Enterocolitis. Am J Pathol. 2013;182(5):1595-606.10.1016/j.ajpath.2013.01.013364472523470164 Search in Google Scholar

11. Turroni F, Peano C, Pass DA, et al. Diversity of Bifi dobacteria within the Infant Gut Microbiota. PLoS ONE. 2012;7(5):e36957.10.1371/journal.pone.0036957335048922606315 Search in Google Scholar

12. Arboleya S, Binetti A, Salazar N, et al. Establishment and development of intestinal microbiota in preterm neonates. FEMS Microbiol Ecol. 2012;79(3):763-72.10.1111/j.1574-6941.2011.01261.x22126419 Search in Google Scholar

13. Lopetuso LR, Scaldaferri F, Petito V, Gasbarrini A. Commensal Clostridia: leading players in the maintenance of gut homeostasis. Gut Pathog. 2013;5(1):23.10.1186/1757-4749-5-23375134823941657 Search in Google Scholar

14. Patel RM, Kandefer S, Walsh MC, et al. Causes and Timing of Death in Extremely Premature Infants from 2000 through 2011. N Engl J Med. 2015;372(4):331-40.10.1056/NEJMoa1403489434936225607427 Search in Google Scholar

15. Derrien M, van Hylckama Vlieg JET. Fate, activity, and impact of ingested bacteria within the human gut microbiota. Trends Microbiol. 2015;23(6):354-66.10.1016/j.tim.2015.03.00225840765 Search in Google Scholar

16. Walker WA. Mechanisms of Action of Probiotics. Clin Infect Dis. 2008 1;46(Supplement 2):S87-91.10.1086/52333518181730 Search in Google Scholar

17. Tremaroli V, Bäckhed F. Functional interactions between the gut microbiota and host metabolism. Nature. 2012;489(7415):242-9.10.1038/nature1155222972297 Search in Google Scholar

18. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012;13(10):701-12.10.1038/nrn334622968153 Search in Google Scholar

19. Sanders ME, Akkermans LM, Haller D, et al. Safety assessment of probiotics for human use. Gut Microbes. 2010;1(3):164-85.10.4161/gmic.1.3.12127302359721327023 Search in Google Scholar

20. Cukrowska B, Bierła JB, Zakrzewska M et al. The Relationship between the Infant Gut Microbiota and Allergy. The Role of Bifi dobacterium breve and Prebiotic Oligosaccharides in the Activation of Anti-Allergic Mechanisms in Early Life. Nutrients. 2020;12(4):946.10.3390/nu12040946723032232235348 Search in Google Scholar

21. Vincent D, Klinke M, Eschenburg G, et al. NEC is likely a NETs dependent process and markers of NETosis are predictive of NEC in mice and humans. Sci Rep. 2018;8(1):12612.10.1038/s41598-018-31087-0 Search in Google Scholar

22. Boudry G, Charton E, Le Huerou-Luron I, et al. The Relationship Between Breast Milk Components and the Infant Gut Microbiota. Front Nutr. 2021;8:629740. doi: 10.3389/fnut.2021.629740. Apri DOISearch in Google Scholar

23. Le Doare K, Holder B, Bassett A, Pannaraj PS. Mother’s Milk: A Purposeful Contribution to the Development of the Infant Microbiota and Immunity. Front Immunol. 2018;9:361. doi: 10.3389/fimmu.2018.00361. Apri DOISearch in Google Scholar

24. Khodayar-Pardo P, Mira-Pascual L, Collado MC, Martínez-Costa C. Impact of lactation stage, gestational age and mode of delivery on breast milk microbiota. J Perinatol. 2014;34(8):599-605.10.1038/jp.2014.47 Search in Google Scholar

25. Green-Johnson JM. Immunological Responses to Gut Bacteria. J AOAC Int. 2012;95(1):35-49.10.5740/jaoacint.SGE_Green-Johnson Search in Google Scholar

26. Caselli M, Cassol F, Calò G et al. Actual concept of “probiotics”: Is it more functional to science or business? World J Gastroenterol. 2013;19(10):1527-40.10.3748/wjg.v19.i10.1527 Search in Google Scholar

27. Sanna S, van Zuydam NR, Mahajan A, et al. Causal relationships between gut microbiome, short-chain fatty acids and metabolic diseases. Nat Genet. 2019;51(4):600-5.10.1038/s41588-019-0350-x Search in Google Scholar

28. Kien CL, McClead RE, Cordero L. Effects of lactose intake on lactose digestion and colonic fermentation in preterm infants. J Pediatr. 1998;133(3):401-5.10.1016/S0022-3476(98)70278-1 Search in Google Scholar

29. Blouin JM, Penot G, Collinet M, et al. Butyrate elicits a metabolic switch in human colon cancer cells by targeting the pyruvate dehydrogenase complex. Int J Cancer. 2011;128(11):2591-601.10.1002/ijc.2559920715114 Search in Google Scholar

30. Nafday SM, Chen W, Peng L et al. Short-Chain Fatty Acids Induce Colonic Mucosal Injury in Rats with Various Postnatal Ages. Pediatr Res. 2005;57(2):201-4.10.1203/01.PDR.0000150721.83224.8915611351 Search in Google Scholar

31. Brooks B, Firek BA, Miller CS, et al. Microbes in the neonatal intensive care unit resemble those found in the gut of premature infants. Microbiome. 2014;2(1):1.10.1186/2049-2618-2-1439251624468033 Search in Google Scholar

32. Wittrock B, Lavin MA, Pierry D et al. Parents as a Vector for Nosocomial Infection in the Neonatal Intensive Care Unit. Infect Control Hosp Epidemiol. 2001;22(08):472.10.1086/50340411700866 Search in Google Scholar

33. Kaufman D, Blackman A, Conaway MR, Sinkin RA. Nonsterile glove use in addition to hand hygiene to prevent late-onset infection in preterm infants: randomized clinical trial. JAMA Pediatr. 2014;168(10):909-16.10.1001/jamapediatrics.2014.95325111196 Search in Google Scholar

34. Indrio F, Salatto A, Amato O, et al. COVID-19 pandemic in the neonatal intensive care unit: any effect on late-onset sepsis and necrotizing enterocolitis? Eur J Pediatr. 2022;181(2):853-7.10.1007/s00431-021-04254-1842106134490508 Search in Google Scholar

35. Ergenekon E, Tayman C, Özkan H. Turkish Neonatal Society Necrotizing Enterocolitis Diagnosis, Treatment and Prevention Guidelines. Turk Arch Pediatr. 2021;56(5):513-524. Search in Google Scholar

36. Bell MJ, Ternberg JL, Feigin RD et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg. 1978;187(1):1-7.10.1097/00000658-197801000-000011396409413500 Search in Google Scholar

37. Kim JH, Sampath V, Canvasser J. Challenges in diagnosing necrotizing enterocolitis. Pediatr Res. 2020;88(1):16-20.10.1038/s41390-020-1090-432855507 Search in Google Scholar

38. Juhl SM, Hansen ML, Gormsen M et al. Staging of necrotising enterocolitis by Bell’s criteria is supported by a statistical pattern analysis of clinical and radiological variables. Acta Paediatr Oslo Nor (1992). 2019;108(5):842-8.10.1111/apa.1446929926969 Search in Google Scholar

39. World Health Organization. WHO recommendations on interventions to improve preterm birth outcomes: evidence base [Internet]. Geneva: World Health Organization; 2015 [cited 2022 May 16]. Available from: https://apps.who.int/iris/handle/10665/183038 Search in Google Scholar

40. Patole S. Prevention and treatment of necrotising enterocolitis in preterm neonates. Early Hum Dev. 2007;83(10):635-42.10.1016/j.earlhumdev.2007.07.00717826009 Search in Google Scholar

41. Parker MG, Stellwagen LM, Noble L et al. Promoting Human Milk and Breastfeeding for the Very Low Birth Weight Infant. Pediatrics. 2021;148(5):e2021054272.10.1542/peds.2021-05427234635582 Search in Google Scholar

42. Barbian ME, Buckle R, Denning PW, Patel RM. To start or not: Factors to consider when implementing routine probiotic use in the NICU. Early Hum Dev. 2019; 135:66-71.10.1016/j.earlhumdev.2019.05.009668423731196719 Search in Google Scholar

43. Manzoni P, Meyer M, Stolfi I, et al. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial. Early Hum Dev. 2014;90:S60-5.10.1016/S0378-3782(14)70020-9 Search in Google Scholar

44. Griffiths J, Jenkins P, Vargova M, et al. Enteral lactoferrin supplementation for very preterm infants: a randomised placebo-controlled trial. The Lancet. 2019;393(10170):423-33.10.1016/S0140-6736(18)32221-9 Search in Google Scholar

45. Manzoni P. Clinical Benefits of Lactoferrin for Infants and Children. J Pediatr. 2016; 173:S43-52.10.1016/j.jpeds.2016.02.07527234411 Search in Google Scholar

46. Sharma R, Tepas JJ, Mollitt DL et al. Surgical management of bowel perforations and outcome in very low-birth-weight infants (< or =1,200 g). J Pediatr Surg. 2004;39(2):190-4.10.1016/j.jpedsurg.2003.10.00514966738 Search in Google Scholar

47. Athalye-Jape G, Patole S. Probiotics for preterm infants – time to end all controversies. Microb Biotechnol. 2019;12(2):249-53.10.1111/1751-7915.13357638984330637944 Search in Google Scholar

48. Neu J. Probiotics and Necrotizing Enterocolitis. Clin Perinatol. 2014;41(4):967-78.10.1016/j.clp.2014.08.014425449425459784 Search in Google Scholar

49. Katan MB. Why the European Food Safety Authority was right to reject health claims for probiotics. Benef Microbes. 2012;3(2):85-9.10.3920/BM2012.000822683835 Search in Google Scholar

50. Core Team R. R: A language and environment for statistical computing. R Foundation for Statistical Computing. Vienna Austria URL Https:www R-Proj OrgGoogle Sch. 2021 Search in Google Scholar

51. RStudio Team. RStudio: Integrated Development Environment for R [Internet]. Boston, MA: RStudio, PBC.; 2021. Available from: http://www.rstudio.com/ Search in Google Scholar

52. Aria M, Cuccurullo C. bibliometrix: An R-tool for comprehensive science mapping analysis. J Informetr. 2017;11(4):959-75.10.1016/j.joi.2017.08.007 Search in Google Scholar

53. A brief introduction to bibliometrix [Internet]. BIBLIOMETRIX. Available from: https://www.bibliometrix.org/vignettes/Introduction_to_bibliometrix.html Search in Google Scholar

54. Millar MR, Bacon C, Smith SL et al. Enteral feeding of premature infants with Lactobacillus GG. Arch Dis Child. 1993 Nov;69(5 Spec No):483-7.10.1136/adc.69.5_Spec_No.48310295898285750 Search in Google Scholar

55. Kitajima H, Sumida Y, Tanaka R et al. Early administration of Bifi dobacterium breve to preterm infants: randomised controlled trial. Arch Dis Child Fetal Neonatal Ed. 1997 Mar;76(2):F101-710.1136/fn.76.2.F10117206339135288 Search in Google Scholar

56. Grönlund MM, Lehtonen OP, Kent P et al. Erratum.: Lactobacillus GG supplementation does not reduce faecal colonization of Klebsiella oxytoca in preterm infants. Acta Paediatr. 1997;86(7):785-6.10.1111/j.1651-2227.1997.tb08594.x Search in Google Scholar

57. Dani C, Biadaioli R, Bertini G et al. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate. 2002 Aug;82(2):103-8.10.1159/000063096 Search in Google Scholar

58. Costalos C, Skouteri V, Gounaris A et al. Enteral feeding of premature infants with Saccharomyces boulardii. Early Hum Dev. 2003; 74(2):89-96.10.1016/S0378-3782(03)00090-2 Search in Google Scholar

59. Lin HC, Su BH, Chen AC, et al. Oral Probiotics Reduce the Incidence and Severity of Necrotizing Enterocolitis in Very Low Birth Weight Infants. Pediatrics. 2005;115(1):1-4.10.1542/peds.2004-1463 Search in Google Scholar

60. Jacobs SE, Tobin JM, Opie GF, et al. Probiotic Effects on Late-onset Sepsis in Very Preterm Infants: A Randomized Controlled Trial. Pediatrics. 2013;132(6):1055-62.10.1542/peds.2013-1339 Search in Google Scholar

61. Costeloe K, Hardy P, Juszczak E et al. Bifi dobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial. The Lancet. 2016;387(10019):649-60.10.1016/S0140-6736(15)01027-2 Search in Google Scholar

62. Zbinden A, Zbinden R, Berger C, Arlettaz R. Case Series of Bifi dobacterium longum Bacteremia in Three Preterm Infants on Probiotic Therapy. Neonatology. 2015;107(1):56-9.10.1159/00036798525402825 Search in Google Scholar

63. Van den Akker CHP, Van Goudoever JB, Shamir R, et al. Probiotics and Preterm Infants: A Position Paper by the European Society for Paediatric Gastroenterology Hepatology and Nutrition Committee on Nutrition and the European Society for Paediatric Gastroenterology Hepatology and Nutrition Working Group for Probiotics and Prebiotics. J Pediatr Gastroenterol Nutr. 2020;70(5):664-80.10.1097/MPG.000000000000265532332478 Search in Google Scholar

64. Manzoni P, Mostert M, Leonessa ML, et al. Oral Supplementation with Lactobacillus casei Subspecies rhamnosus Prevents Enteric Colonization by Candida Species in Preterm Neonates: A Randomized Study. Clin Infect Dis. 2006;42(12):1735-42.10.1086/50432416705580 Search in Google Scholar

65. Rougé C, Piloquet H, Butel MJ et al. Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2009;89(6):1828-35.10.3945/ajcn.2008.2691919369375 Search in Google Scholar

66. Mihatsch WA, Vossbeck S, Eikmanns B et al. Effect of Bifidobacterium lactis on the Incidence of Nosocomial Infections in Very-Low-Birth-Weight Infants: A Randomized Controlled Trial. Neonatology. 2010;98(2):156-63.10.1159/00028029120234140 Search in Google Scholar

67. Stratiki Z, Costalos C, Sevastiadou S, et al. The effect of a bifi dobacter supplemented bovine milk on intestinal permeability of preterm infants. Early Hum Dev. 2007;83(9):575-9.10.1016/j.earlhumdev.2006.12.00217229535 Search in Google Scholar

68. Mohan R, Koebnick C, Schildt J et al. Effects of Bifi dobacterium lactis Bb12 Supplementation on Body Weight, Fecal pH, Acetate, Lactate, Calprotectin, and IgA in Preterm Infants. Pediatr Res. 2008;64(4):418-22.10.1203/PDR.0b013e318181b7fa18552710 Search in Google Scholar

69. Sari FN, Dizdar EA, Oguz S et al. Oral probiotics: Lactobacillus sporogenes for prevention of necrotizing enterocolitis in very low-birth weight infants: a randomized, controlled trial. Eur J Clin Nutr. 2011;65(4):434-9.10.1038/ejcn.2010.27821245887 Search in Google Scholar

70. Braga TD, da Silva GAP, de Lira PIC et al. Efficacy of Bifi dobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: a double-blind, randomized, controlled trial. Am J Clin Nutr. 2011;93(1):81-6.10.3945/ajcn.2010.2979920980486 Search in Google Scholar

71. Rojas MA, Lozano JM, Rojas MX, et al. Prophylactic Probiotics to Prevent Death and Nosocomial Infection in Preterm Infants. Pediatrics. 2012;130(5):e1113-20.10.1542/peds.2011-358423071204 Search in Google Scholar

72. Esaiassen E, Cavanagh P, Hjerde E et al. Bifi dobacterium longum Subspecies infantis Bacteremia in 3 Extremely Preterm Infants Receiving Probiotics. Emerg Infect Dis. 2016;22(9):1664-6.10.3201/eid2209.160033499434527532215 Search in Google Scholar

73. Borriello SP, Hammes WP, Holzapfel W, et al. Safety of Probiotics That Contain Lactobacilli or Bifi dobacteria. Clin Infect Dis. 2003;36(6):775-80.10.1086/36808012627362 Search in Google Scholar

74. Bury S, Soundararajan M, Bharti R et al. The Probiotic Escherichia coli Strain Nissle 1917 Combats Lambdoid Bacteriophages stx and λ. Front Microbiol. 2018;9:929.10.3389/fmicb.2018.00929598706929896160 Search in Google Scholar

75. Jenke A, Ruf EM, Hoppe T et al. Bifi dobacterium septicaemia in an extremely low-birthweight infant under probiotic therapy. Arch Dis Child Fetal Neonatal Ed. 2012;97(3):F217-218.10.1136/archdischild-2011-30083822058179 Search in Google Scholar

76. Dani C, Coviello CC, Corsini II et al. Lactobacillus Sepsis and Probiotic Therapy in Newborns: Two New Cases and Literature Review. AJP Rep. 2016;6(1):e25-9.10.1055/s-0035-1566312473762826929865 Search in Google Scholar

77. Mack DR. D(—)–Lactic Acid Producing Probiotics, D(—)–Lactic Acidosis and Infants. Can J Gastroenterol. 2004;18(11):671-5.10.1155/2004/34258315565207 Search in Google Scholar

78. Shida K, Nanno M, Nagata S. Flexible cytokine production by macrophages and T cells in response to probiotic bacteria: A possible mechanism by which probiotics exert multifunctional immune regulatory activities. Gut Microbes. 2011;2(2):109–14.10.4161/gmic.2.2.1566121637028 Search in Google Scholar

79. Lutgendorff F, Trulsson LM, Minnen LP et al. Probiotics enhance pancreatic glutathione biosynthesis and reduce oxidative stress in experimental acute pancreatitis. Am J Physiol – Gastrointest Liver Physiol. 2008;295(5):G1111-21.10.1152/ajpgi.00603.200718832452 Search in Google Scholar

80. European Medicines Agency. Scientific conclusions and grounds for the variation to the terms of the Marketing Authorisation(s) – saccharomyces boulardii. 2020. Search in Google Scholar

81. Lin HY, Chang JH, Chung MY, Lin HC. Prevention of necrotizing enterocolitis in preterm very low birth weight infants: Is it feasible? J Formos Med Assoc. 2014;113(8):490-7.10.1016/j.jfma.2013.03.01023701837 Search in Google Scholar

82. Alfaleh K, Anabrees J, Bassler D, Al-Kharfi T. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev. 2011;(3):CD005496. doi: 10.1002/14651858.CD005496.pub3. Update in: Cochrane Database Syst Rev. 2014;4:CD005496.21412889 Apri DOISearch in Google Scholar

83. Deshpande GC, Rao SC, Keil AD, Patole SK. Evidencebased guidelines for use of probiotics in preterm neonates. BMC Med. 2011;9:92.10.1186/1741-7015-9-92316361621806843 Search in Google Scholar

84. Van den Akker CHP, Van Goudoever JB, Szajewska H et al. Probiotics for Preterm Infants: A Strain-Specific Systematic Review and Network Meta-analysis. J Pediatr Gastroenterol Nutr. 2018;67(1):103-22.10.1097/MPG.000000000000189729384838 Search in Google Scholar

85. Poindexter B, Committee On fetus and newborn, Cummings J, Hand I, Adams-Chapman et al. Use of Probiotics in Preterm Infants. Pediatrics. 2021 Jun 1;147(6):e2021051485.10.1542/peds.2021-05148534031231 Search in Google Scholar

86. Juber BA, Boly TJ, Pitcher GJ, McElroy SJ. Routine Administration of a Multispecies Probiotic Containing Bifidobacterium and Lactobacillus to Very Low Birth Weight Infants Had No Significant Impact on the Incidence of Necrotizing Enterocolitis. Front Pediatr. 2021;9:757299. doi: 10.3389/fped.2021.757299.858126234778147 Apri DOISearch in Google Scholar

87. Bhadoria P, Mahapatra S. Prospects, technological aspects and limitations of probiotics–a worldwide review. Eur J Food Res Rev. 2011;1(2):23-42. Search in Google Scholar

88. Ritchie ML, Romanuk TN. A Meta-Analysis of Probiotic Efficacy for Gastrointestinal Diseases. 2012;7(4):e34938. doi: 10.1371/journal.pone.0034938.332954422529959 Apri DOISearch in Google Scholar

89. Binns N. Probiotics, prebiotics and the gut microbiota. Brussels: ILSI Europe; 2013. Search in Google Scholar

90. Licht TR, Baggesen DL. EFSA BIOHAZ Panel (EFSA Panel on Biological Hazards), 2013. Scientific Opinion on the maintenance of the list of QPS biological agents intentionally added to food and feed (2013 update). European Food Safety Authority; 2013. Search in Google Scholar

91. Lewis ZT, Shani G, Masarweh CF, et al. Validating bifi dobacterial species and subspecies identity in commercial probiotic products. Pediatr Res. 2016;79(3):445-52.10.1038/pr.2015.244491696126571226 Search in Google Scholar

92. Vallabhaneni S, Walker TA, Lockhart SR, et al. Fatal Gastrointestinal Mucormycosis in a Premature Infant Associated with a Contaminated Dietary Supplement – Connecticut, 2014. Morb Mortal Wkly Rep. 2015;64(6):155-6. Search in Google Scholar

93. Georgieva M, Andonova L, Peikova L, Zlatkov A. Probiotics – Health Benefits, Classification, Quality Assurance аnd Quality Control – Review. Pharmacia. 2014; 61(4):22-31. Search in Google Scholar

Articoli consigliati da Trend MD

Pianifica la tua conferenza remota con Sciendo